Skip to main content
Journal cover image

Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid

Publication ,  Journal Article
Ridpath, AV; Rzepka, PV; Shearer, SM; Scrape, SR; Olencki, TE; Kaffenberger, BH
Published in: International Journal of Dermatology
November 2018

Duke Scholars

Published In

International Journal of Dermatology

DOI

EISSN

1365-4632

ISSN

0011-9059

Publication Date

November 2018

Volume

57

Issue

11

Start / End Page

1372 / 1374

Publisher

Wiley

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ridpath, A. V., Rzepka, P. V., Shearer, S. M., Scrape, S. R., Olencki, T. E., & Kaffenberger, B. H. (2018). Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid. International Journal of Dermatology, 57(11), 1372–1374. https://doi.org/10.1111/ijd.13970
Ridpath, Alyson V., Polina V. Rzepka, Sabrina M. Shearer, Scott R. Scrape, Thomas E. Olencki, and Benjamin H. Kaffenberger. “Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid.” International Journal of Dermatology 57, no. 11 (November 2018): 1372–74. https://doi.org/10.1111/ijd.13970.
Ridpath AV, Rzepka PV, Shearer SM, Scrape SR, Olencki TE, Kaffenberger BH. Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid. International Journal of Dermatology. 2018 Nov;57(11):1372–4.
Ridpath, Alyson V., et al. “Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid.” International Journal of Dermatology, vol. 57, no. 11, Wiley, Nov. 2018, pp. 1372–74. Crossref, doi:10.1111/ijd.13970.
Ridpath AV, Rzepka PV, Shearer SM, Scrape SR, Olencki TE, Kaffenberger BH. Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid. International Journal of Dermatology. Wiley; 2018 Nov;57(11):1372–1374.
Journal cover image

Published In

International Journal of Dermatology

DOI

EISSN

1365-4632

ISSN

0011-9059

Publication Date

November 2018

Volume

57

Issue

11

Start / End Page

1372 / 1374

Publisher

Wiley

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences